BrightSpring Health Services Inc

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

BrightSpring Health Services Inc reports strong Q2 performance and growth outlook

BrightSpring Health Services Inc demonstrated strong financial performance in Q2 2024, driven by robust revenue growth and improved adjusted EBITDA. The company's strategic focus on serving complex patient populations, expanding its pharmacy segments, and recognizing employee contributions positions it for continued success.
Despite potential challenges in managing growth complexities and regulatory changes, BrightSpring Health Services has opportunities to further expand its service offerings, enhance its Provider Services segment, and drive growth through strategic acquisitions and operational efficiencies.
Overall, BrightSpring Health Services Inc's Q2 earnings call highlighted a positive outlook, emphasizing its commitment to high-quality care, operational excellence, and growth through a combination of organic strategies and accretive acquisitions.

BrightSpring Health Services excels in Q3, eyes sustained growth

BrightSpring Health Services reported robust financial results in Q3, with strong revenue and EBITDA growth across key segments. The company's strategic acquisitions and focus on operational efficiency are driving performance.
While facing challenges in cost management and operational optimization, BrightSpring Health Services is actively pursuing opportunities for growth through capital deployment and enhanced patient care services.
With a positive outlook for Q4 and 2025, the company's emphasis on governance, strategic leadership, and market expansion positions it well for continued success and value creation for stakeholders.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BrightSpring Health Services, Inc. engages in the provision of a platform of complementary health services delivering and pharmacy solutions for complex populations in home and community settings. It operates under the Pharmacy Solutions and Provider Services segments. The Pharmacy Solutions segment includes infusion and specialty pharmacy, and home and community pharmacy. The Provider Services segment is involved in home health care and community and rehab care. The company was founded in 1974 and is headquartered in Louisville, KY.

LOUISVILLE, Ky., April 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced that on April 24, 2024, BrightSpring appointed Timothy A. Wicks as a new member of the Board of Directors. Mr. Wicks will assume his new role effective immediately, bringing the Company's total Board of Directors to seven members, including two independent directors.

BrightSpring Health Services, Inc. Welcomes Timothy A. Wicks to Board of Directors

LOUISVILLE, Ky., April 10, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) announced today that its company Onco360®, a leading independent oncology pharmacy, was selected as a national pharmacy partner by Alexion Pharmaceuticals for a first-in-class, oral, Factor D inhibitor, Voydeya® (Danicopan) to treat patients with a rare, life-threatening disease of the blood called paroxysmal nocturnal hemoglobinuria (PNH) who are experiencing extravascular hemolysis (EVH).

BrightSpring Health Services Specialty Pharmacy Onco360® Selected as National Pharmacy Partner for Voydeya®

LOUISVILLE, Ky., April 09, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its first quarter 2024 financial results on Thursday, May 2, 2024, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day.

BrightSpring Health Services, Inc. to Announce First Quarter 2024 Financial Results on May 2, 2024, and Participate in the Bank of America 2024 Healthcare Conference

LOUISVILLE, Ky., April 04, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or “the Company”) (NASDAQ: BTSG) applauds its most recent employees and programs for their dedicated service, care, and innovation, which has resulted in ongoing and additional national recognition by industry publications and trade associations.

BrightSpring Health Services Applauds Hundreds of Award-Winning Employees for their Recognition of Outstanding Service and Care

LOUISVILLE, Ky., March 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced several recent tuck-in acquisitions within its service lines and geographies that continue to support market penetration and market density growth strategies, including a Maryland home health operation, a behavioral therapy company in Michigan and a long-term care pharmacy in Montana.

BrightSpring Health Services Announces Recent Acquisitions That Continue to Drive Growth and Value

Kirtley brings deep business experience and financial expertise to further Company's mission Kirtley brings deep business experience and financial expertise to further Company's mission

BrightSpring Welcomes Olivia Kirtley to Board of Directors

LOUISVILLE, Ky., March 14, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) announced today that its company, Onco360®, one of the nation's largest independent oncology pharmacies, is now the national specialty pharmacy network partner for a first-in-class, XPO-1 inhibitor, XPOVIO® (selinexor) to treat patients with multiple myeloma. Onco360® currently has 116 limited distribution drugs in its portfolio, in partnership with pharmaceutical and biotech companies.

BrightSpring Health Services' Specialty Pharmacy Onco360® Celebrates Excellent Patient Care and Preferred Pharmacy Status

BrightSpring Health Services, Inc. (BTSG) Q4 2023 Earnings Call Transcript

LOUISVILLE, Ky., Feb. 29, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today financial results for the fourth quarter and full year ended December 31, 2023.

BrightSpring Health Services, Inc. Reports Financial Results for Fourth Quarter and Full Year 2023 and Provides Full Year 2024 Guidance

LOUISVILLE, Ky., Feb. 15, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its fourth quarter and full year 2023 financial results on Thursday, February 29, 2024, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day.

BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results and Hold Investor Conference Call on February 29, 2024

BrightSpring Health Services' IPO has underperformed due to concerns about its high debt and slim margins. The company operates in the home and community healthcare services sector, focusing on senior and specialty patients. Despite its national scale and potential for growth through M&A, the company's fundamental performance and leverage raise concerns for investors.

BrightSpring Health Services: A Leveraged And Low Margin Healthcare IPO

CG oncology Inc

American Healthcare REIT Inc., Fortegra Group Inc. and Fractyle Health Inc. set proposed price ranges in their upcoming initial public offerings on Monday, after a mixed reception to two deals late last week.

American Healthcare REIT, Fortegra and Fractyle Health set IPO price ranges as thaw continues

LOUISVILLE, Ky., Jan. 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) today marked its first day of trading on Nasdaq following the pricing of its initial public offering on January 25, 2024.

BrightSpring Celebrates First Day of Trading on Nasdaq

BrightSpring Health Services Inc. said late Thursday that its initial public offering priced at $13 a share, below its proposed range of $15 to $18.

BrightSpring's IPO prices below range to raise $693 million

LOUISVILLE, Ky.--(BUSINESS WIRE)--BrightSpring Health Services, Inc. (“BrightSpring” or “BrightSpring Health Services”) today announced the pricing of an initial public offering of 53,333,334 shares of its common stock at $13.00 per share and a concurrent offering of 8,000,000 of its 6.75% tangible equity units (“Units”), with a stated amount of $50.00 per Unit. Shares of BrightSpring's common stock and the Units are expected to begin trading on the NASDAQ Global Select Market on January 26, 20.

BrightSpring Health Services Announces Pricing of its Initial Public Offering and Concurrent Offering of Tangible Equity Units

BrightSpring Health Services, which is owned by private equity firm KKR & Co , is considering pricing its initial public offering at below its targeted range, according to a person familiar with the matter.

KKR-backed BrightSpring set to price IPO below targeted range-source

The U.S. initial public offering market is facing another busy week with at least $1 billion worth of deals expected to come, led by healthcare services provider BrightSpring Health Services Inc. That company is planning to raise up to $959.4 million by offering 53.3 million shares priced at $15 to $18 each. That would give the company a valuation of $3.1 billion.

U.S. IPO market facing another $1 billion week with BrightSpring and CG Oncology on tap

CCSC Technology International Holdings Ltd

JVSPAC Acquisition Corp

Kyverna Therapeutics Inc

Two foreign issuers listed in the US this past week, joined by one blank check. Four IPOs joined the pipeline, as well as one SPAC. JVSPAC Acquisition raised $50 million in the year's first blank check IPO. The SPAC plans to target business at the intersection of lifestyle and technology. More sizable issuers are lining up for January IPOs, with two currently scheduled for the week ahead.

U.S. IPO Weekly Recap: Kaspi.Kz Completes Billion-Dollar U.S. Listing As More Big Names Join The Pipeline

It may be cold out there, but the initial public offering (IPO) market isn't completely frozen over. BrightSpring, a company providing in-home and community health services, just announced plans for an IPO.

BTSG Stock IPO: When Does BrightSpring Go Public? What Is the BrightSpring IPO Price Range?

BrightSpring Health Services, Inc. plans to raise $880 million in an IPO. The company's revenue growth has slowed significantly over the years. The IPO appears to be richly priced on slowing growth, so I'm Neutral [Hold] on the BrightSpring Health Services, Inc. IPO.

News for BrightSpring Health Services Inc Stock (BTSG)